CHA News Article

CDC Releases Updated Guidance on Multistate Outbreak of Fungal Infections

The Centers for Disease Control and Prevention (CDC) released Oct. 23 updated interim guidance based on new data that has become available during its ongoing investigation of the multistate outbreak of fungal infections. According to the CDC, patients who have received an epidural or paraspinal injection with contaminated products are at greatest risk during the first six weeks after the injection. Health care providers should therefore consider additional monitoring of these patients. The CDC provides guidance for these patients as well as for those who received such products longer than six weeks ago. For specific details, see the CDC’s Guidance for Management of Asymptomatic Persons Exposed to Potentially Contaminated Steroid Products. For the most recent information on the outbreak and investigation, visit